Growth Metrics

Evolent Health (EVH) Cash from Operations (2016 - 2026)

Evolent Health has reported Cash from Operations over the past 11 years, most recently at 48800000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 286.04% year-over-year to 48800000.0; the TTM value through Dec 2025 reached 38843000.0, up 107.0%, while the annual FY2025 figure was 38843000.0, 107.0% up from the prior year.
  • Cash from Operations for Q4 2025 was 48800000.0 at Evolent Health, up from 15812000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 89381000.0 in Q4 2023 and troughed at 57442000.0 in Q1 2022.
  • A 5-year average of 11369200.0 and a median of 9286500.0 in 2022 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: surged 3174.77% in 2024 and later crashed 241.64% in 2025.
  • Year by year, Cash from Operations stood at 66656000.0 in 2021, then plummeted by 46.45% to 35695000.0 in 2022, then surged by 150.4% to 89381000.0 in 2023, then crashed by 129.35% to 26231000.0 in 2024, then skyrocketed by 286.04% to 48800000.0 in 2025.
  • Business Quant data shows Cash from Operations for EVH at 48800000.0 in Q4 2025, 15812000.0 in Q3 2025, and 30334000.0 in Q2 2025.